Successful Treatment of Hepatitis C Virus by Ledipasvir/Sofosbuvir in a Cirrhotic Patient with Sickle Cell Disease and Thalassemia Minor

Successful Treatment of Hepatitis C Virus by Ledipasvir/Sofosbuvir in a Cirrhotic Patient with Sickle Cell Disease and Thalassemia Minor

Around 8% of patients diagnosed with sickle cell disease (SCD) are hepatitis C virus (HCV) carriers. Previously, HCV treatment was seldom considered in SCD patients, as the ribavirin-induced hemolysis and interferon-induced cytopenias could lead to more profound anemia. Nowadays, several oral direct...

Full description

Bibliographic Details
Main Authors: Hassan Al Moussawi, Abhishek D. Polavarapu, Divya Asti, Zainab Awada, Stephen  Mulrooney
Format: Article
Language:English
Published: Karger Publishers 2018-10-01
Series:Case Reports in Gastroenterology
Subjects:
Hepatitis C virus
Ledipasvir/sofosbuvir
Sickle cell disease
Online Access:https://www.karger.com/Article/FullText/493421

Similar Items

Similar Items